These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 28710479)
1. Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization. Wang Y; Chen DQ; Chen MY; Ji KY; Ma DX; Zhou LF Sci Rep; 2017 Jul; 7(1):5463. PubMed ID: 28710479 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects respond to cerebral ischemia without susceptibility to HB-tumorigenesis in VHL heterozygous knockout mice. Wang Y; Yang J; Du G; Ma D; Zhou L Mol Carcinog; 2017 Oct; 56(10):2342-2351. PubMed ID: 28574654 [TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay. Wang Y; Chen D; Chen M; Ji K; Ma D; Zhou L J Vis Exp; 2018 Apr; (134):. PubMed ID: 29708531 [TBL] [Abstract][Full Text] [Related]
4. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. Stratmann R; Krieg M; Haas R; Plate KH J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235 [TBL] [Abstract][Full Text] [Related]
5. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619 [TBL] [Abstract][Full Text] [Related]
7. Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma. Kruizinga RC; van Marion DM; den Dunnen WF; de Groot JC; Hoving EW; Oosting SF; Timmer-Bosscha H; Derks RP; Cornelissen C; van der Luijt RB; Links TP; de Vries EG; Walenkamp AM Fam Cancer; 2016 Oct; 15(4):607-16. PubMed ID: 26920352 [TBL] [Abstract][Full Text] [Related]
8. VHL-deficient vasculogenesis in hemangioblastoma. Gläsker S; Smith J; Raffeld M; Li J; Oldfield EH; Vortmeyer AO Exp Mol Pathol; 2014 Apr; 96(2):162-7. PubMed ID: 24394472 [TBL] [Abstract][Full Text] [Related]
9. Study of angiogenic signaling pathways in hemangioblastoma. Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534 [TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097 [TBL] [Abstract][Full Text] [Related]
12. CXCL11 mediates TWIST1-induced angiogenesis in epithelial ovarian cancer. Koo YJ; Kim TJ; Min KJ; So KA; Jung US; Hong JH Tumour Biol; 2017 May; 39(5):1010428317706226. PubMed ID: 28488542 [TBL] [Abstract][Full Text] [Related]
13. Expression of growth factors and growth factor receptors in capillary hemangioblastoma. Böhling T; Hatva E; Kujala M; Claesson-Welsh L; Alitalo K; Haltia M J Neuropathol Exp Neurol; 1996 May; 55(5):522-7. PubMed ID: 8627342 [TBL] [Abstract][Full Text] [Related]
14. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity. Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390 [TBL] [Abstract][Full Text] [Related]
15. CD41 and CD45 expression marks the angioformative initiation of neovascularisation in human haemangioblastoma. Ma D; Wang Y; Du G; Yang J; Tang Q; Zhou L Tumour Biol; 2016 Mar; 37(3):3765-74. PubMed ID: 26468019 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas. Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148 [TBL] [Abstract][Full Text] [Related]
17. MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway. Wang L; Zhou R; Zhao Y; Dong S; Zhang J; Luo Y; Huang N; Shi M; Bin J; Liao Y; Liao W PLoS One; 2016; 11(6):e0157137. PubMed ID: 27280289 [TBL] [Abstract][Full Text] [Related]
18. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas. Taïeb D; Barlier A; Yang C; Pertuit M; Tchoghandjian A; Rochette C; Zattara-Canoni H; Figarella-Branger D; Zhuang Z; Pacak K; Metellus P J Neurooncol; 2016 Feb; 126(3):473-81. PubMed ID: 26514359 [TBL] [Abstract][Full Text] [Related]
19. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene. Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223 [TBL] [Abstract][Full Text] [Related]
20. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma. Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]